Penbraya Side Effects

Generic name: meningococcal group acwy conjugate-group b vaccine (cvx 316)

Note: This document contains side effect information about meningococcal group acwy conjugate-group b vaccine (cvx 316). Some dosage forms listed on this page may not apply to the brand name Penbraya.

Applies to meningococcal group acwy conjugate-group b vaccine (cvx 316): intramuscular suspension.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Keep track of all side effects you have, be sure to tell the vaccination provider if the previous shot caused any side effects.

You should not receive a second shot if you had a life-threatening allergic reaction after the first shot.

Becoming infected with meningococcal disease and developing meningitis is much more dangerous to your health than receiving this vaccine. Any vaccine may cause side effects but the risk of serious side effects is low.

You may feel faint after receiving this vaccine. Your doctor may want you to remain under observation during the first 15 minutes after the injection.

Common side effects may include:

• headache;

• feeling tired;

• muscle or joint pain;

• chills; or

• pain, redness, swelling, or irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to meningococcal group acwy conjugate-group b vaccine (cvx 316): intramuscular suspension.

General

The most common adverse reactions reported after receiving both doses of this vaccine were pain at the injection site, muscle pain, fatigue, headache, injection site swelling and redness, joint pain, and chills.^[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (up to 11%)

Common (1% to 10%): Vomiting

Hypersensitivity

Postmarketing reports: Allergic reaction (including anaphylaxis)^[Ref]

Local

Very common (10% or more): Injection site pain (up to 89.3%), injection site redness (up to 25.9%), injection site swelling (up to 25%)

Musculoskeletal

Very common (10% or more): Joint pain (up to 20.2%), muscle pain (up to 25.7%)^[Ref]

Other

Common (1% to 10%): Fever

Nervous system

Very common (10% or more): Chills (up to 20.1%), fatigue (up to 52.1%), headache (up to 46.8%)

Postmarketing reports: Syncope (fainting)^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer